An AAVP-based solid-phase transducing matrix for transgene delivery: potential for translational applications.

T L Smith1,2, G R Souza3,4, R L Sidman5

  • 1University of New Mexico Comprehensive Cancer Center, Albuquerque, NM, USA.

Cancer Gene Therapy
|May 27, 2017
PubMed
Summary

Researchers developed a novel gold nanoparticle-AAVP hybrid vector, creating a "transducing matrix" for enhanced gene delivery. This nanoplatform significantly improves targeted gene delivery efficiency in solid phases, offering new therapeutic possibilities.

Related Concept Videos